| Prev Close: | 43.76 |
|---|---|
| Open: | 43.82 |
| Bid: | 44.04 x 700 |
| Ask: | 44.05 x 300 |
| 1y Target Est: | 39.30 |
| Beta: | 0.12 |
| Next Earnings Date: | 22-Jul-13 |
| Day's Range: | 43.63 - 44.44 |
|---|---|
| 52wk Range: | 30.64 - 45.59 |
| Volume: | 5,005,001 |
| Avg Vol (3m): | 10,019,000 |
| Market Cap: | 71.69B |
| P/E (ttm): | 49.89 |
| EPS (ttm): | 0.88 |
| Div & Yield: | 1.40 (3.20%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Bristol-Myers Squibb Director Sells More Than 215K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Tue 9:40AM EDT)
- Cramer's Top Stock Picks: SAVE GILD BMY HTA TSLAat TheStreet(Tue 6:00AM EDT)
- Cramer's Watch List Ahead of Big Cancer Conferenceat CNBC(Mon, May 20)
- [video] The War Against Cancerat CNBC(Mon, May 20)
- Final Glance: Pharmaceuticals companiesAP(Mon, May 20)
- Teva Bets on Reformulating Old Drugs as Investors Say ‘Show Me’at Bloomberg(Mon, May 20)
- Bristol Myers Squibb And The New Wave Of Cancer Drugsat Seeking Alpha(Mon, May 20)
- Will Amgen's Novel Drug Revolutionize Cancer Treatment?at Motley Fool(Mon, May 20)
- Midday Glance: Pharmaceuticals companiesAP(Mon, May 20)
- 5 Drugs Stocks On The Riseat TheStreet(Mon, May 20)
- 1 Pioneering Device to Jump-Start the Cardiovascular Industryat Motley Fool(Mon, May 20)
- Early Glance: Pharmaceuticals companiesAP(Mon, May 20)
- Shire advances after report renews takeover speculationat theflyonthewall.com(Mon, May 20)
- [video] Monday's Market Roadmapat CNBC(Mon, May 20)
- Leerink estimates Shire takeout value at least $110 per shareat theflyonthewall.com(Mon, May 20)
Press Releases
- Bristol-Myers Squibb Announces Intention to Voluntarily Delist Preferred StockBusiness Wire(Thu, May 16)
- Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO HighlightsBusiness Wire(Wed, May 15)
- Bristol-Myers Squibb Advances Leadership Position in Immuno-Oncology with Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual MeetingBusiness Wire(Wed, May 15)
Reports
- Company Snapshot - Bristol Myers Squibb CoDirectors Deals Ltd.(May 21)
- BMY: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 21)
- ValuEngine Industry Report for Large CAP PharmaValuEngine, Inc.(May 21)